Iambic jobs, careers, and hiring context

Explore Iambic careers: 32 open roles hiring now. Find jobs at Iambic with direct links to apply. Funding stage: Series B. Headcount: 51-200. Iambic Therapeutics is a clinical-stage biotech in San Diego using a physics-informed generative AI platform (NeuralPLexer, Enchant) to design and advance small-molecule cancer therapeutics. It has a lead HER2 inhibitor (IAM1363) in Phase 1/1b trials and major partnerships with Takeda, Jazz, and others, and filed an S-1 for a US IPO in September 2026.

This page summarizes open roles, company profile signals, and official application paths so candidates can quickly evaluate fit before applying. Use the role list below to identify team focus, review location patterns, and jump to source listings. For broader comparison across the market, continue to the full company directory and jobs explorer.

Open roles
32
Funding stage
Series B
Total funding
$461.8M

Key facts

Iambic is a Series B stage AI startup, founded in 2019, with $461.8M in total disclosed funding. Its most recent round was a $27.8M Series B in Apr 2026. It currently lists 32 open roles across US Remote, San Diego HQ, Boston Office, +1 more. Source: Fast AI Jobs company dataset, updated Oct 2026.

Sample open roles from this company

Role links below go directly to official listing pages. Use them as a fast path while the full interactive view loads.

Company profile last updated on Oct 12, 2026.